|
The CDC has a requirement for scientific assessment of the potential risks, costs, and benefits of vaccination for policy purposes and to establish academic clinical centers of excellence with expertise in vaccine safety.
The proposed project is in keeping with the mission of the National Immunization Program in... The scope of this opportunity is expected to include performing Phase IV and Phase V post-licensure/ marketing evaluation of safety of vaccines used in children and adolescents 0-17 years of age. It is anticipated that the prime contractor shall select 6-8 health plans (or sites) with experience in performing clinical outcome
...
|
*
|
* This information is only available to Subscribed Users.
